Clinical Trial Results:
A Phase II Multi-Dose Study of SGN-30 (anti-CD30 mAb) in Patients with
Refractory or Recurrent Hodgkin’s Disease or Anaplastic Large Cell Lymphoma
Summary
|
|
EudraCT number |
2004-000607-17 |
Trial protocol |
SE DK BE IT |
Global completion date |
30 Dec 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Jan 2017
|
First version publication date |
17 Jan 2017
|
Other versions |
|
Summary report(s) |
SG030-0003 CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.